Cargando…

Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.

Gene-transfected tumour cells were used to cure mice bearing lung metastases by the parental, non-transduced mammary adenocarcinoma (TSA-pc). Repeated subcutaneous (s.c.) administrations of mitomycin C (MitC)-treated interferon gamma (IFN-gamma) transfectants induced a 90% inhibition in the number o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanni, P., De Giovanni, C., Landuzzi, L., Nicoletti, G., Frabetti, F., Rossi, I., Cavallo, F., Giovarelli, M., Forni, G., Lollini, P. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074840/ https://www.ncbi.nlm.nih.gov/pubmed/8932336

Ejemplares similares

Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.
por: Nanni, P., et al.
Publicado: (1992)

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
por: De Giovanni, Carla, et al.
Publicado: (2019)

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
por: Boggio, Katia, et al.
Publicado: (1998)

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.
por: De Giovanni, C., et al.
Publicado: (1995)

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.
por: Nanni, P., et al.
Publicado: (1991)

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
por: Nanni, Patrizia, et al.
Publicado: (2001)

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.
por: De Giovanni, C., et al.
Publicado: (1998)

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
por: Nicoletti, G., et al.
Publicado: (1992)

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.
por: Lauri, D., et al.
Publicado: (1993)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Nanni, Patrizia, et al.
Publicado: (2018)

Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes.
por: Giovarelli, M., et al.
Publicado: (1976)

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
por: De Giovanni, C., et al.
Publicado: (1993)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
por: De Giovanni, Carla, et al.
Publicado: (2014)

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
por: De Giovanni, Carla, et al.
Publicado: (2021)

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model
por: Pantaleo, M. A., et al.
Publicado: (2009)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Giusti, Veronica, et al.
Publicado: (2021)

Designing of interferon-gamma inducing MHC class-II binders
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2013)

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
por: De Giovanni, Carla, et al.
Publicado: (2019)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
por: Shah, P., et al.
Publicado: (1989)

Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue
por: Doppler, W, et al.
Publicado: (2005)

Transcription of class II MHC gene by interferon-gamma in FRTL-5 cells.
por: Lee, M. S., et al.
Publicado: (1992)

Selective Stimulation of Duplicated Atlantic Salmon MHC Pathway Genes by Interferon-Gamma
por: Grimholt, Unni, et al.
Publicado: (2020)

An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention
por: Cavallo, Federica, et al.
Publicado: (2005)

2011: the immune hallmarks of cancer
por: Cavallo, Federica, et al.
Publicado: (2011)

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
por: Palladini, Arianna, et al.
Publicado: (2017)

Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma
por: Sarvetnick, Nora, et al.
Publicado: (1988)

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice
por: De Giovanni, C, et al.
Publicado: (2012)

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
por: De Giovanni, Carla, et al.
Publicado: (2019)

Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.
por: Nanni, P., et al.
Publicado: (1981)

Protective role of interferon gamma in murine antigen-induced arthritis
por: Hückel, M, et al.
Publicado: (2004)

The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM
por: Smith, Abigail L., et al.
Publicado: (1991)

The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis
por: Denson, Kayla E., et al.
Publicado: (2018)

Development of drug resistance in a murine mammary tumour.
por: McMillan, T. J., et al.
Publicado: (1985)

Measurement of the branching ratio $\Lambda (X^{0} \rightarrow \gamma \gamma )/ \gamma^{0} \rightarrow$ total)
por: Dalpiaz, P, et al.
Publicado: (1972)

Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
por: Jabrane-Ferrat, N., et al.
Publicado: (1990)

Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor
Publicado: (1984)

Further evidence for the decay mode $X^{0} \rightarrow \gamma \gamma$ and determination of the branching ratio $X^{0} \rightarrow \gamma \gamma /X^{0} \rightarrow$ total
por: Basile, M, et al.
Publicado: (1971)

The Transcriptome of Type I Murine Astrocytes under Interferon-Gamma Exposure and Remyelination Stimulus
por: Kudriaeva, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_247baj43hv9krum491gu15kuub